A total of four adult and young adult female Macaca fascicularis monkeys were used in these experiments. The surgical procedures were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh, and were in full accordance with those outlined by the Guide for Care and Use of Animals and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Before the injection procedures were carried out, the animals were sedated with ketamine HCl (10–15 mg/kg, IM) and then placed under general anesthesia by use of isoflurane (3.0% in O2). Ophthalmic proparacaine drops were placed in each eye. Animals received buprenorphine HCl (0.01 mg/kg, IM) as a postoperative analgesic at the conclusion of the procedure.
The experimental rationale is illustrated in
Figure 1. The ciliary muscle of one eye (e.g., left) was injected with a recombinant rabies virus that produces a green fluorescent protein (GFP) marker. The ciliary muscle of the other eye (e.g., right) was injected with a recombinant rabies virus that produces a red fluorescent marker (mCherry). Both recombinant viruses were taken up by postganglionic parasympathetic fibers and transported back to their cell bodies in their respective ciliary ganglia. After replication there, they crossed the synapse and were taken up by the axons of preganglionic parasympathetic motoneurons. Retrograde transport brought them to the ipsilateral EWpg. Consequently, after replication, they would fluoresce with the marker injected into the ipsilateral muscle. The virus then crossed the synapse into the terminals of the premotor neurons, and was taken up and retrogradely transported by their axons to their somata. After replication, those premotor neurons supplying the left EWpg would fluoresce green, those supplying the right EWpg would fluoresce red, and any cells supplying both EWpg nuclei would fluoresce with both markers, and so appear yellow/orange in the merged image.
All surgeries, postoperative survivals, and perfusions took place at the Center for Neuroanatomy with Neurotropic Viruses at the University of Pittsburgh directed by Dr Peter L. Strick. In each case, the ciliary muscle of one eye was injected with 150 µL of a solution containing 1 × 10
9 Pfu/mL of a recombinant N2c rabies virus that produces GFP (N2c-GFP). The ciliary muscle of the other eye was injected with 150 µL of a solution containing 1 × 10
9 Pfu/mL of a recombinant N2c rabies virus that produces a red fluorescent protein, mCherry (N2c-mCherry). These recombinant viruses were developed by Drs Matthias Schnell and Christoph Wirblich of Thomas Jefferson University. The virus was held in a 100-µL Hamilton syringe equipped with a 25G needle. Multiple (12–15) small (∼10 µL) injections were made at different locations on the globe by driving the needle through the sclera at the corneal/conjuctival junction. The medial and ventromedial aspect of the ciliary body could not be accessed. Animals survived for 72 (
n = 1), 76 (
n = 1), and 80 hours (
n = 2). They were then resedated with ketamine and deeply anesthetized with sodium pentobarbital (40 mg/kg, IP). Once insensate, they underwent a cardiac perfusion with phosphate buffered (0.1 M, pH 7.4) saline, followed by 10% formalin in phosphate buffer (0.1M, pH 7.4), and followed in turn by buffered formalin containing 5% glycerol. The brains were blocked in the frontal plane and post-fixed in a 10% glycerol-buffered formalin solution for 7 days at 4°C. Several ganglia (ciliary, trigeminal, pterygopalatine, and superior cervical) were also extracted and processed to test for the presence of rabies virus (for details
8). Of these, only the ciliary ganglia contained labeled cells, indicating that uptake by other postganglionic motoneurons supplying the eye did not occur.
The brainstems of these animals were frozen and cut into 50 µm thick sections. Every fifth section was reacted to reveal the presence of the two markers using antibodies to GFP (goat polyclonal antibody: Abcam # 5450; Abcam, Cambridge, UK) and to DsRed, which cross-reacts with mCherry (rabbit polyclonal antibody: Clonetech # 632496; Clonetech, Mountain View, CA). Specifically, sections were first rinsed in 0.1 M, pH 7.5 phosphate tris-buffered saline with 0.05% sodium azide (PTA). They were then placed in immunoblocking serum consisting of 10% normal donkey serum in PTA with 0.5% Triton-X 100 for 2 hours. They were incubated in a primary antibody solution consisting of 1:200 goat anti-GFP (Novus Biologicals # NB100-1770; Novus Biologicals, Littleton, CO) and 1:1000 rabbit anti-DsRed (TaKaRa #632496; TaKaRa, Mountain View, CA) in PTA with 10% normal donkey serum and Triton-X 100 for 2 days at 4°C with gentle agitation. After rinsing, the primary antibodies were subsequently tagged with fluorescent secondary antibodies: donkey anti-goat IgG conjugated to green fluorescing Alexa Fluor 488 (Jackson ImmunoResearch # 705-545-147; Jackson ImmunoResearch, West Grove, PA) and donkey anti-rabbit IgG conjugated to red fluorescing Alexa Fluor 594 (Jackson ImmunoResearch # 711-585-152). These were diluted 1:300 and 1:500, respectively, in a solution of PTA with 10% normal donkey serum and 0.3% triton-X-100. After incubating for 2 hours at room temperature in the secondary antibody solution, the sections were rinsed and mounted onto glass slides. Once they had dried, they were coverslipped under nonfluorescing medium. Control sections in which the primary or secondary antibody was omitted were run and they showed very weak or no fluorescence.
An adjacent series of sections was mounted onto glass slides, counterstained with cresyl violet, dehydrated, cleared, and coverslipped to provide a cytoarchitectonic context for the location of fluorescent-labeled cells. To measure the effectiveness of the labeling with the recombinant viruses and fluorescence procedures, another series was incubated in a mouse monoclonal antibody to the rabies virus (diluted 1:1000) as the primary antibody. (This was a gift of Dr Matthias Schnell of Thomas Jefferson University [designated clone 31G10]). The primary antibody was tagged with biotinylated anti-mouse IgG and revealed using a Vector Labs ABC kit (Vector Labs, Burlingame, CA), followed by DAB immunohistochemistry. The details of this procedure can be found in our previous study.
8
Sections were analyzed by use of a Nikon E600 fluorescence photomicroscope equipped with a Nikon Ds-Ri1 digital camera. Nikon Elements software was used to import the images into the computer. Image contrast and brightness were adjusted in Photoshop to appear as similar as possible to the viewed image. Color prints of the images were used to create chartings of the label, with borders supplied by comparison with adjacent Nissl-stained sections. In each case, we used prints of the images obtained with the filters for the mCherry (TRITC excitation bandwidth 525–553) and the GFP marker (FITC excitation bandwidth 465–495). These images were compared with the merged image to make sure singly and doubly labeled neurons were correctly identified. In addition, we consulted an image taken with the filters for blue fluorescent markers (UV excitation bandwidth 330–380) to ensure that the cells were not simply fluorescing due to the presence of lipofuscin or other nonspecific labeling.